-
Subject Areas :
1 -
Keywords: -,
Abstract :
-
References:
1. Lendlein A., Shastri V.P., “Stimuli-Sensitive Polymers”, Adv. Mater. 22, 3344–3347, 2010.
2. Hatefi A., Amsden B., “Biodegradable Injectable in-situ Forming Drug Delivery Systems”, J. Control. Release 80, 9–28, 2002.
3. Abashzadeh S., Dinarvand R., Sharifzadeh M., Hassanzadeh G., Amini M., Atyabi F., “Formulation and Evaluation of an In-situ Gel Forming System for Controlled Delivery of Triptorelin Acetate”, Eur. J. Pharm. Sci. 4, 514–521, 2011.
4. Gil E., Hudson S., “Stimuli- Reponsive Polymers and Their Bio Conjugates”, Prog. Polym. Sci. 29, 1173–1222, 2004.
5. Renard P., Jordan O., Faes A., Petri-Fink A., Hofmann H., Ru D., Bosman F., “The In-vivo Performance of Magnetic Particle-Loaded Injectable, In-situ Gelling, Carriers for The Delivery of Local Hyperthermia”, Biomaterials 31, 691–705, 2010.
6. Dunn R.L., English J.P., Cowsar D.R., Vanderbilt D.P., “Biodegradable in-Situ Forming Implants and Methods of Producing the Same”, US Patents 4,938,763, 1990.
7. Matschke C., Isele U., Van Hoogevest P., Fahr A., “Sustained- Release Injectable Formed In-situ and Their Potential Use for Veterinary Products”, J. Control. Release 85, 1–15, 2002.
8. DesNoyer J.R., McHugh A.J., “Role of Crystallization in The Phase Inversion Dynamics and Protein Release Kinetics of Injectable Drug Delivery Systems”, J. Control. Release 70, 285–294, 2001.
9. Thakur RR, McMillan HL, Jones DS. “Solvent Induced Phase Inversion-Based In-situ Forming Controlled Release Drug Delivery Implants”, J. Control. Release 176, 8–23, 2014.
10. Jamshidi K., Hyon S.-H., Ikada Y., “Thermal Characterization of Poly Lactides”, Polymer 29, 2229–2234, 1988.
11. Lee J., Jallo G.I., Penno M.B., Gabrielson K.L., Young G.D., Johnson R.M., Rampersaud C., Carson BS., Guarnieri M., “Intracranial Drug-Delivery Scaffolds: Biocompatibility Evaluation of Sucrose Acetate Isobutyrate Gels”, Toxicol. Appl. Pharmacol. 215, 64–70, 2006.
12. Lin X., Yang S., Gou J., Zhao M., Zhang Y., Qi N., He H., Cai C., Tang X., Guo P., “A Novel Risperidone- Loaded SAIB-PLGA Mixture Matrix Depot with a Reduced Burst Release: Effects of Solvents and PLGA on Drug Release Behaviours In-vitro/In-vivo”, J. Mater. Sci. Mater. Med. 23,443–455, 2012.
13. Dunn R.L., English J.P., Cowsar D.R., Vanderbilt D.D., “Biodegradable In-situ Forming Implants and Methods of Producing the Same”, US Patent 5,278,202, 2004.
14. Brodbeck K.J., Gaynor-Duarte A.T., Shen T., “Gel Composition and Methods”, US Patent 6,130,200, 2000.
15. Chern R.T., Zingerman J.R., “Liquid Polymeric Compositions for Controlled Release of Bio Active Substances”, US Patent 10/753,724, 2004.
16. Schoenhammer K., Petersen H., Guethlein F., Goepferich A., “Poly (Ethylene Glycol)500 Dimethyl Ether as Novel Solvent for Injectable In-situ Forming Depots”, Pharm.Res. 26, 2568–2577, 2009.
17. Raman C., McHugh A.J., “A Model for Drug Release from Fast Phase Inverting Injectable Solutions”, J. Control. Release 102, 145–157, 2005.
18. Fredenberg S., Wahlgren M., Reslow M., Axelsson A., “The Mechanisms of Drug Release in Poly (Lactic-co-Glycolic Acid)- Based Drug Delivery Systems- A Review”, Int. J. Pharm. 415, 34–55, 2011.
19. Zare M., Mobedi H., Barzin J., Mivehchi H., Jamshidi A., Mashayekhi R., “Effect of Additives on Release Profile of Leuprolide Acetate in An In-situ Forming Controlled- Release System: In-vitro Study”, J. App. Polym. Sci. 107, 3781–3787, 2008.
20. Omelczuk M.O., McGinity J.W., “The Influence of Polymer Glass Transition Temperature and Molecular Weight on Drug Release from Tablets Containing Poly (DL-Lactic Acid")”, Pharm. Res. 9, 26–32, 1992.
21. Göpferich A., “Polymer Degradation and Erosion: Mechanisms and Applications”, Eur. J. Pharm. Biopharm. 42, 1–11, 1996.
22. Miyajima M., Koshika A., Okada J., Ikeda M., Nishimura K., “Effect of Polymer Crystallinity on Papaverine Release from Poly (L-Lactic Acid) Matrix”, J. Control. Release 49, 207–215, 1997.
23. Juvekar S., Kathpalia H., “Solvent Removal Precipitation Based In-situ Forming Implant for Controlled Drug Delivery in Periodontitis”, J. Control. Release. 2017.
24. Rahimi M., Mobedi H., Behnamghader A., In-situ Forming Poly (Lactic Acid-co-Glycolic Acid) Implants containing Leuprolide Acetate/β-cyclodextrin Complexes: Preparation, Characterization, and In-vitro Drug Release, Int. J. Polym. Mater. Polym. Biomater. 65(2), 75-84, 2015.
25. Dong W.Y., Körber M., López V. Esguerra, Bodmeier R., “Stability of Poly (D, L Lactide-co-Glycolide) and Leuprolide Acetate in In-situ Forming Drug Delivery Systems”, J. Control. Release 115, 158–167, 2006.
26. Astaneh R., Erfan M., Barzin J., Mobedi H., “Effects of Ethyl Benzoate on Performance, Morphology, and Erosion of PLGA Implants Formed In-situ”, Adv. Polym. Technol. 2717–26, 2008.
27. Lee S.S., Hughes P., Ross A.D., Robinson M.R., “Biodegradable Implants for Sustained Drug Release in The Eye”, Pharm. Res. 27, 2043–2053, 2010.
28. Kempe S., Mäder K., “In-situ Forming Implants- An Attractive Formulation Principle for Parenteral Depot Formulations” , J. Control. Release 161, 668–679, 2012.
1. Lendlein A., Shastri V.P., “Stimuli-Sensitive Polymers”, Adv. Mater. 22, 3344–3347, 2010.
2. Hatefi A., Amsden B., “Biodegradable Injectable in-situ Forming Drug Delivery Systems”, J. Control. Release 80, 9–28, 2002.
3. Abashzadeh S., Dinarvand R., Sharifzadeh M., Hassanzadeh G., Amini M., Atyabi F., “Formulation and Evaluation of an In-situ Gel Forming System for Controlled Delivery of Triptorelin Acetate”, Eur. J. Pharm. Sci. 4, 514–521, 2011.
4. Gil E., Hudson S., “Stimuli- Reponsive Polymers and Their Bio Conjugates”, Prog. Polym. Sci. 29, 1173–1222, 2004.
5. Renard P., Jordan O., Faes A., Petri-Fink A., Hofmann H., Ru D., Bosman F., “The In-vivo Performance of Magnetic Particle-Loaded Injectable, In-situ Gelling, Carriers for The Delivery of Local Hyperthermia”, Biomaterials 31, 691–705, 2010.
6. Dunn R.L., English J.P., Cowsar D.R., Vanderbilt D.P., “Biodegradable in-Situ Forming Implants and Methods of Producing the Same”, US Patents 4,938,763, 1990.
7. Matschke C., Isele U., Van Hoogevest P., Fahr A., “Sustained- Release Injectable Formed In-situ and Their Potential Use for Veterinary Products”, J. Control. Release 85, 1–15, 2002.
8. DesNoyer J.R., McHugh A.J., “Role of Crystallization in The Phase Inversion Dynamics and Protein Release Kinetics of Injectable Drug Delivery Systems”, J. Control. Release 70, 285–294, 2001.
9. Thakur RR, McMillan HL, Jones DS. “Solvent Induced Phase Inversion-Based In-situ Forming Controlled Release Drug Delivery Implants”, J. Control. Release 176, 8–23, 2014.
10. Jamshidi K., Hyon S.-H., Ikada Y., “Thermal Characterization of Poly Lactides”, Polymer 29, 2229–2234, 1988.
11. Lee J., Jallo G.I., Penno M.B., Gabrielson K.L., Young G.D., Johnson R.M., Rampersaud C., Carson BS., Guarnieri M., “Intracranial Drug-Delivery Scaffolds: Biocompatibility Evaluation of Sucrose Acetate Isobutyrate Gels”, Toxicol. Appl. Pharmacol. 215, 64–70, 2006.
12. Lin X., Yang S., Gou J., Zhao M., Zhang Y., Qi N., He H., Cai C., Tang X., Guo P., “A Novel Risperidone- Loaded SAIB-PLGA Mixture Matrix Depot with a Reduced Burst Release: Effects of Solvents and PLGA on Drug Release Behaviours In-vitro/In-vivo”, J. Mater. Sci. Mater. Med. 23,443–455, 2012.
13. Dunn R.L., English J.P., Cowsar D.R., Vanderbilt D.D., “Biodegradable In-situ Forming Implants and Methods of Producing the Same”, US Patent 5,278,202, 2004.
14. Brodbeck K.J., Gaynor-Duarte A.T., Shen T., “Gel Composition and Methods”, US Patent 6,130,200, 2000.
15. Chern R.T., Zingerman J.R., “Liquid Polymeric Compositions for Controlled Release of Bio Active Substances”, US Patent 10/753,724, 2004.
16. Schoenhammer K., Petersen H., Guethlein F., Goepferich A., “Poly (Ethylene Glycol)500 Dimethyl Ether as Novel Solvent for Injectable In-situ Forming Depots”, Pharm.Res. 26, 2568–2577, 2009.
17. Raman C., McHugh A.J., “A Model for Drug Release from Fast Phase Inverting Injectable Solutions”, J. Control. Release 102, 145–157, 2005.
18. Fredenberg S., Wahlgren M., Reslow M., Axelsson A., “The Mechanisms of Drug Release in Poly (Lactic-co-Glycolic Acid)- Based Drug Delivery Systems- A Review”, Int. J. Pharm. 415, 34–55, 2011.
19. Zare M., Mobedi H., Barzin J., Mivehchi H., Jamshidi A., Mashayekhi R., “Effect of Additives on Release Profile of Leuprolide Acetate in An In-situ Forming Controlled- Release System: In-vitro Study”, J. App. Polym. Sci. 107, 3781–3787, 2008.
20. Omelczuk M.O., McGinity J.W., “The Influence of Polymer Glass Transition Temperature and Molecular Weight on Drug Release from Tablets Containing Poly (DL-Lactic Acid")”, Pharm. Res. 9, 26–32, 1992.
21. Göpferich A., “Polymer Degradation and Erosion: Mechanisms and Applications”, Eur. J. Pharm. Biopharm. 42, 1–11, 1996.
22. Miyajima M., Koshika A., Okada J., Ikeda M., Nishimura K., “Effect of Polymer Crystallinity on Papaverine Release from Poly (L-Lactic Acid) Matrix”, J. Control. Release 49, 207–215, 1997.
23. Juvekar S., Kathpalia H., “Solvent Removal Precipitation Based In-situ Forming Implant for Controlled Drug Delivery in Periodontitis”, J. Control. Release. 2017.
24. Rahimi M., Mobedi H., Behnamghader A., In-situ Forming Poly (Lactic Acid-co-Glycolic Acid) Implants containing Leuprolide Acetate/β-cyclodextrin Complexes: Preparation, Characterization, and In-vitro Drug Release, Int. J. Polym. Mater. Polym. Biomater. 65(2), 75-84, 2015.
25. Dong W.Y., Körber M., López V. Esguerra, Bodmeier R., “Stability of Poly (D, L Lactide-co-Glycolide) and Leuprolide Acetate in In-situ Forming Drug Delivery Systems”, J. Control. Release 115, 158–167, 2006.
26. Astaneh R., Erfan M., Barzin J., Mobedi H., “Effects of Ethyl Benzoate on Performance, Morphology, and Erosion of PLGA Implants Formed In-situ”, Adv. Polym. Technol. 2717–26, 2008.
27. Lee S.S., Hughes P., Ross A.D., Robinson M.R., “Biodegradable Implants for Sustained Drug Release in The Eye”, Pharm. Res. 27, 2043–2053, 2010.
28. Kempe S., Mäder K., “In-situ Forming Implants- An Attractive Formulation Principle for Parenteral Depot Formulations” , J. Control. Release 161, 668–679, 2012.